Medicine & Health

A study from School of Medicine researchers, published in the journal Nature, has found evidence that the immune response to the first two COVID-19 vaccines authorized by the FDA is both strong and potentially long-lasting.

Cyrus Raji, MD, PhD, assistant professor of radiology and of neurology at the School of Medicine, received a three-year $2.3 million grant from the National Institute on Aging of the National Institutes of Health (NIH) for his research titled “Neuroinflammation and Alzheimer’s Disease Imaging Biomarkers in Midlife Obesity.”

The virus that causes COVID-19 normally gets inside cells by attaching to a protein called ACE2. School of Medicine researchers have found that a single mutation confers the ability to enter cells through another route.

Researchers at the School of Medicine have identified ingredients for snack food prototypes that have been formulated to deliberately change the gut microbiome in ways that can be linked to health.

An investigational Alzheimer’s drug showed mixed results, reducing molecular markers of disease and curbing neurodegeneration, without demonstrating evidence of cognitive benefit, in a clinical trial led by School of Medicine researchers.

Researchers at Washington University School of Medicine have found that high levels of a normal protein associated with reduced heart disease also protect against Alzheimer’s-like damage in mice, opening up new approaches to slowing or stopping brain damage and cognitive decline in people with Alzheimer’s.

Catherine Lang, professor of physical therapy at the School of Medicine, has been appointed to serve on a national child health council for the Eunice Kennedy Schriver National Institute of Child Health and Human Development of the National Institutes of Health (NIH).

COVID-19 vaccines rolled out on an unprecedented timetable, but the world is still at risk.

In the early days of the pandemic, personal protective equipment was in short supply in the U.S., and its availability continues to be a problem globally, leaving health-care workers and their communities exposed. Jennifer DeLaney, MD ’97, has been on a remarkable journey leading a local effort to help.

New research at Washington University School of Medicine suggests that many COVID-19 therapies made from combinations of two antibodies are effective against a wide range of variants of the virus.